U.S. Gov’t Guidance Permits DNA Traceability, Isotopic Testing as Evidence
June 21st, 2022
All Categories
APDN in the News
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
Press Release
Uncategorized
Vaccines
Category: Press Release
Positive Preclinical Data for LinearDNA™ as Novel Cancer Vaccine Strategy
June 7th, 2022
Applied DNA Reports Second Quarter Fiscal 2022 Financial Results
May 12th, 2022
APDN Schedules FY’22 Q2 Results Conference Call & Webcast
May 9th, 2022
APDN Awarded NYC-based ‘Return-to-Office’ Health Services Contract
April 6th, 2022
Applied DNA to Participate in 2022 Maxim Virtual Growth Conference
March 23rd, 2022
Spindle Biotech Research Collaboration on mRNA Production System
March 14th, 2022
Applied DNA Announces Closing of $4.2 Million Registered Direct Offering
February 25th, 2022
APDN Announces Pricing of $4.2 Million Registered Direct Offering
February 22nd, 2022
